This page shows Xinda Intl (XNDA) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
SUPA’s dominant mechanic is balance-sheet expansion without matching cash generation, leaving it equity-funded yet still chronically liquidity-constrained.
Between FY2023 and FY2025, total assets jumped from$178K to$5.2M , a balance-sheet step-change rather than normal operating drift. Yet FY2025 cash and operating cash flow were both just$17.7K , which means the larger asset base has not yet become a reliable source of liquidity or self-funding capacity.
FY2024’s reported profit of
The liquidity picture is much weaker than the debt picture: FY2025 ended with a current ratio of 0.02x and no long-term debt, so solvency and day-to-day funding are telling different stories. Shares outstanding also jumped to 290.8M from 39.9M in FY2024, spreading any future economics across far more shares while cash remained thin.
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of Xinda Intl's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Xinda Intl carries a low D/E ratio of 0.00, meaning only $0.00 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.
Xinda Intl's current ratio of 0.02 is below the typical benchmark, resulting in a score of 0/100. This tight liquidity could limit financial flexibility if cash inflows slow.
Xinda Intl generates a -7.3% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 2/100. This is down from 1.3% the prior year.
Xinda Intl passes 2 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).
For every $1 of reported earnings, Xinda Intl generates $-0.06 in operating cash flow ($18K OCF vs -$293K net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
Key Financial Metrics
Earnings & Revenue
Xinda Intl's EBITDA was -$407K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
Xinda Intl reported -$293K in net income in fiscal year 2025. This represents a decrease of 654.6% from the prior year.
Cash & Balance Sheet
Xinda Intl held $18K in cash against $0 in long-term debt as of fiscal year 2025.
Xinda Intl had 291M shares outstanding in fiscal year 2025. This represents an increase of 628.3% from the prior year.
Margins & Returns
Xinda Intl's ROE was -7.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 8.5 percentage points from the prior year.
Capital Allocation
Xinda Intl spent $0 on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 100.0% from the prior year.
XNDA Income Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $170K | N/A | $127K-15.5% | $151K+710.7% | $19K | N/A | $4K | $0 |
| Operating Income | -$170K | N/A | -$127K+15.5% | -$151K-710.7% | -$19K | N/A | -$4K | $0 |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | $0 | N/A | $0 | $0 | $0 | N/A | $0 | $0 |
| Net Income | -$186K | N/A | -$144K+11.5% | -$163K-216.4% | $140K | N/A | -$22K | $0 |
| EPS (Diluted) | $0.00 | N/A | $0.00 | $0.00 | $0.00 | N/A | $0.00 | $0.00 |
XNDA Balance Sheet
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.2M+0.3% | $5.2M-0.7% | $5.2M+1.0% | $5.1M+2.7% | $5.0M0.0% | $5.0M+3409.8% | $142K0.0% | $142K |
| Current Assets | $41K+59.2% | $26K-57.9% | $61K+453.0% | $11K | $0 | $0 | $0 | $0 |
| Cash & Equivalents | $19K+7.1% | $18K-66.7% | $53K+1687.2% | $3K | $0 | $0 | $0 | $0 |
| Inventory | $14K | $0 | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $1.3M+18.1% | $1.1M+8.9% | $1.0M+23.4% | $828K+26.5% | $654K-17.9% | $797K-12.5% | $911K+2.6% | $888K |
| Current Liabilities | $1.3M+18.1% | $1.1M+8.9% | $1.0M+23.4% | $828K+26.5% | $654K-17.9% | $797K-12.5% | $911K+2.6% | $888K |
| Long-Term Debt | $368K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Equity | $3.9M-4.6% | $4.0M-3.0% | $4.2M0.0% | $4.2M-4.2% | $4.3M+3.4% | $4.2M+646.8% | -$769K-3.0% | -$746K |
| Retained Earnings | -$3.3M-6.0% | -$3.1M-4.3% | -$3.0M-5.1% | -$2.8M-6.1% | -$2.7M+5.0% | -$2.8M+4.0% | -$2.9M-0.8% | -$2.9M |
XNDA Cash Flow Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$138K-382.6% | $49K-71.6% | $171K+145.5% | -$377K-316.1% | $174K+141.1% | $72K+2510.2% | -$3K | $0 |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | $5.0M | $0 | $0 |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | -$4.9M-164156.5% | -$3K | $0 |
| Investing Cash Flow | $0+100.0% | -$84K | $0-100.0% | $84K | $0-100.0% | $142K | $0 | $0 |
| Financing Cash Flow | $139K | $0+100.0% | -$121K-141.0% | $296K+269.5% | -$174K+18.8% | -$215K-7258.7% | $3K | $0 |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
XNDA Financial Ratios
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | -4.8% | N/A | -3.5%+0.5pp | -3.9%-7.1pp | 3.2% | N/A | N/A | N/A |
| Return on Assets | -3.6% | N/A | -2.8%+0.4pp | -3.2%-6.0pp | 2.8% | N/A | -15.5%-15.5pp | 0.0% |
| Current Ratio | 0.030.0 | 0.02-0.0 | 0.06+0.0 | 0.01+0.0 | 0.000.0 | 0.000.0 | 0.000.0 | 0.00 |
| Debt-to-Equity | 0.10+0.1 | 0.000.0 | 0.000.0 | 0.000.0 | 0.000.0 | 0.000.0 | 0.000.0 | 0.00 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: The current ratio is below 1.0 (0.02), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
Is Xinda Intl profitable?
No, Xinda Intl (XNDA) reported a net income of -$293K in fiscal year 2025.
What is Xinda Intl's EBITDA?
Xinda Intl (XNDA) had EBITDA of -$407K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Xinda Intl have?
As of fiscal year 2025, Xinda Intl (XNDA) had $18K in cash and equivalents against $0 in long-term debt.
What is Xinda Intl's return on equity (ROE)?
Xinda Intl (XNDA) has a return on equity of -7.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Xinda Intl's operating cash flow?
Xinda Intl (XNDA) generated $18K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Xinda Intl's total assets?
Xinda Intl (XNDA) had $5.2M in total assets as of fiscal year 2025, including both current and long-term assets.
What is Xinda Intl's current ratio?
Xinda Intl (XNDA) had a current ratio of 0.02 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Xinda Intl's debt-to-equity ratio?
Xinda Intl (XNDA) had a debt-to-equity ratio of 0.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Xinda Intl's return on assets (ROA)?
Xinda Intl (XNDA) had a return on assets of -5.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Xinda Intl's Piotroski F-Score?
Xinda Intl (XNDA) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Xinda Intl's earnings high quality?
Xinda Intl (XNDA) has an earnings quality ratio of -0.06x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Xinda Intl?
Xinda Intl (XNDA) scores 17 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.